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1. Introduction 
Neurologic causes of profound weakness in an ICU (Intensive Care Unit) patient include 
disorders of the central nervous system (CNS) and the peripheral nervous system (PNS). 
Some of these are primary neurologic disorders that result in admission to the ICU, whereas 
others occur while the patient experiences prolonged hospitalization for unrelated medical 
problems. 
These numerous non neurologic medical causes mainly including ischemic or hemorrhagic 
strokes, respiratory failure followed by COPD (chronic obstructive pulmonary disease) and 
asthma, acute or chronic renal failure, complications of ischemic heart diseases such as 
myocardial infarction and consequences of malignant processes. Most of these patients 
undergo mechanical ventilation, some of whom would subsequently be affected by 
neuromuscular disorders. 
From the point of view of electroneurophysiology, these disorders are divided into three 
categories: 1) Critical Illness Neuropathy (CIN), 2) Critical Illness Myopathy (CIM), and 3) 
Prolonged Neuromuscular Junction Blockage [1]. 
In the present chapter, all of three above mentioned disorders as well as two axonal variants 
of Guillain-Barré Syndrome (GBS), namely Acute Motor Axonal Neuropathy (AMAN) and 
Acute Motor and Sensory Axonal Neuropathy (AMSAN) will be discussed in detail, which 
have differential diagnostic importance in distinguishing the etiology of weakness in 
critically-ill patients. Furthermore, we would have a glimpse into our experience derived 
from 14 hospitalized patients with prominent clinical picture of profound weakness, 
studying and comparing their neuromuscular disorders as clinical, electrodiagnostic, 
underlying diseases and incidence rate aspects, individually. 
 
Advances in Clinical Neurophysiology 110 
2. Clinical presentation 
Major clinical manifestation of these disorders includes a progressive weakness of the 
upper and lower extremities or all four limbs as quadriplegia or paraplegia along with 
hyporeflexia, hypotonia, with or without atrophy and weakness of the respiratory 
muscles. 
The most common scenario commence with ICU hospitalization of the patients due to 
serious non-neurological medical reasons including above-mentioned etiologies (renal 
failure, COPD exacerbation, cerebral and gastrointestinal hemorrhage etc.). Majority of these 
patients are dependent on the ventilator and require neuromuscular junction blocking 
agents (NMBAs). During the recovery phase, the focus is on tapering sedatives and NMBAs 
which could be associated with occurrence of flaccid weakness in the upper and lower 
extremities and respiratory muscles; this in turns would delay weaning process from the 
ventilator [2]. On the other hand, patient status is likely to deteriorate toward sepsis or 
multi-organ failure and becoming ventilator-dependent for a long time. Performing 
electrodiagnostic tests to detect neuromuscular disorders delaying extubation is, hence, 
highly-indicated at this stage. 
2.1. Electrodiagnostic studies in ICU patients, technical issues 
Although electrodiagnostic (EDX) studies are mainly performed in outpatient setting, the 
number of the EDX studies in inpatient setting or hospitalized patients in ICU has recently 
been increased [2]. There is a number of challenging technical issues unique to performing 
EDX studies in the ICU and complicated ill patients. Some are related to patient factors, 
whereas others involve central and intravenous lines and electrical equipment that interfere 
with the performance of the study.  
As previously mentioned, in these cases patients are profoundly ill, often with several 
serious overlapping medical problems. Most are intubated and receiving mechanical 
ventilation, which prevents them from traveling to the EMG laboratory, necessitating  
a portable study. But portable EDX device has its own problems such as interference 
with other electrical devices attached to the patient in ICU, noise and artifact 
production and increasing the potential risk of an electrical injury for sensitive  
patients.  
These patients are often poorly cooperative and heavily sedated or agitated, who would 
not be able to roll on the sides or maintain positions required for performing the sensory 
or motor electrodiagnostic tests. Neither the agitated patient nor the sedated patient is 
able to give the electromyographer proper feedback during the study, for example, 
whether he or she is feeling the stimulus during the nerve conduction studies. Nor can 
such patients place their limbs in the correct position for the nerve conduction studies or 
the spontaneous activity assessment portion of the needle examination. Finally, they 
cannot cooperate with the examiner to activate their muscles voluntarily when trying to 
assess motor unit action potentials (MUAPs) during the needle examination [2].  
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3. Our study patients 
Fourteen hospitalized patients from the Pulmonology ICU, Neurology and Internal 
Medicine wards with primary or secondary progressive weakness of the upper and 
lower limbs with or without respiratory muscles involvement were referred to the 
electrodiagnostic center, Physical Medicine and Rehabilitation department, Imam Reza 
Hospital, Tabriz, Iran in a one and half year period from August 2010 to February 2012.  
In order to evaluate neuromuscular disorders and to diagnose the causes of weakness 
electro-neurophysiologically, Nerve Conduction Study and Needle Electromyography 
(NCS-EMG) were performed in all of referred patients. The data related to these patients 
including age, sex, admission reason, underlying diseases, past medical history, final 
diagnosis ,treatments and outcome are presented in Table-1. 
A total of 14 patients were selected and examined. Based on NCS-EMG studies, patients 
were diagnosed as CIN in 4, CIM in 3, neuromyopathic critical illness in 4; including two 
patients with a combination of CIM and CIN and other two patients with previous acute or 
chronic neuropathy and superimposed subsequent CIM, AMAN in 2 and AMSAN only in 
one patient. We would briefly discuss about clinical and electrodiagnostic principals, 
techniques and features each of these entities in the next sections. 
4. Critical Illness Neuropathy (CIN) 
CIN or CIP (Critical Illness Polyneuropathy) is reported as the most common severe 
neuropathy in ICU patients, mostly observed in patients hospitalized due to primary non-
neurological medical problems. The main reason for its occurrence is a reactive systemic 
inflammatory response to sepsis or trauma [2]. Unlike GBS, CIN is an axonal 
polyneuropathy and considered whenever there are signs of fixed weakness in the 
extremities, sensory loss or inability to wean from the ventilator despite beginning clinical 
improvement of the patient. 
Although CIN has been reported to be more frequent than CIM in several studies [3], in a 
study with 88 patients, the incidence ratio of CIM was reported to be three times more than 
CIN (42% vs. 13%). The results of this study showed that among patients who underwent 
EMG in ICU population, acute myopathy is three times as common as acute axonal 
polyneuropathy, and the outcomes from acute myopathy and acute axonal polyneuropathy 
may be similar [4]. In other words, mortality and morbidity are comparable in both of them. 
In addition to polyneuropathy, mononeuropathies including unilateral or bilateral phrenic 
neuropathy are frequently seen in CIN, which contribute to respiratory disorders requiring 
EDX for accurate diagnosis [2]. 
4.1. Electrophysiologic features in CIN 
Although, as above mentioned, EDX is associated with difficulties in ill and complicated 
patients, based on previous studies as well as present study results, electrodiagnostic 
findings could be summarized as the following: 
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Compound muscle action potentials (CMAPs) are profoundly reduced in amplitude or 
absent. Motor conduction velocities are normal or slightly reduced and distal latencies are 
normal or slightly prolonged, while sensory nerve action potentials (SNAPs) should be 
significantly diminished in amplitude or unobtainable. Phrenic nerve study also reveals 
absence or reduction of obtained CMAP from diaphragm muscle, which will be explained in 
the end of this section. 
In pure CIN, neurogenic pattern including high amplitude and polyphasic motor unit action 
potentials (MUAPs) with reduced recruitment are observed in needle electromyography [5]. 
However, patients are sometimes unable to perform motor units recruitment and nothing 
could be detected due to patients' poor effort. In these situations, the only observable sign in 
the needle EMG would be presence of denervation potentials (fib/psw) at the rest phase of 
needle exam.  
Electrodiagnostic criteria of the present study were based on these principals and all  
of above-mentioned characteristics were applied to our patients diagnosed with CIN as 
well.  
Some points should be highlighted regarding the EDX findings in CIN: firstly, if SNAPs 
were normal or mildly low amplitude associated with diminished CMAPs, other 
diagnosis rather than CIN would be investigated i.e. CIM (critical illness myopathy) or 
AMAN (motor axonal neuropathy). At this point, needle EMG differentiates these two 
entities from each other. Secondly, another fact to be kept in mind is that low amplitude 
SNAPs could be related to previous underlying disease such as diabetes or renal failure 
and subsequent diabetic or uremic neuropathy rather than CIN. Thirdly, in cases with 
mixed CIN and CIM, in spite of the fact that SNAPs are abnormal, myogenic pattern in 
needle EMG demonstrates muscle weakness may be more related to the superimposed 
myopathy.  
4.2. Phrenic nerve electrodiagnostic study 
One of the major reasons contributing to unsuccessful weaning trials from the ventilator  
in intubated patients is unilateral or bilateral phrenic neuropathy which could be  
idiopathic, due to autoimmune or post-infection etiologies such as Bell’s palsy and 
secondary to iatrogenic causes after coronary artery bypass grafting or other thoracic 
surgeries [2]. 
Phrenic nerve could also be affected as an accompanying disorder observed with 
polyneuropathies such as GBS or CIN. To obtain phrenic nerve CMAP, recording electrode 
is secured a few centimeters proximal to the xyphoid process while the reference electrode 
being placed 16 cm lower along with the ribcage on both sides corresponding to the phrenic 
nerve excited. Stimulation electrode is placed 3 cm superior to the clavicle parallel to the 
cricoid cartilage [6]. The important issue is that normal amplitude for phrenic CMAP is 300-
500 µv which in fact could be associated with unclear responses due to the electrical noise 
existing in the ICU.  
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No. of 
Patients 
Age sex
The cause of 
admission 
Underlying 
disease 
Past Medical History
Progress of disease and 
outcome 
Electrodiagno
stic 
Impression 
# 1 64 M Respiratory failure gastric cancer 
Surgery of total 
Gastrectomy, 
IHD,Asthma
Mechanical ventilation, 
worsening of general status 
,expire
CINa 
# 2 63 F Acute pancreatitis - - 
Treatment of pancreatitis 
and recovery
CIN 
# 3 36 M 
Acute Respiratory 
distress Syndrome 
(ARDS)
Methadone 
poisoning 
Addiction 
GI bleeding, hypoxic 
Encephalopathy+ Intubation 
CIN 
# 4 66 M 
Acute renal failure 
(ARF) 
ATNb secondary 
to over dosage 
of NSAIDs 
NSAIDs intake 
because of 
musculoskeletal 
problems
Treatment of Pneumonia, 
Hemodialysis for ARF, 
recovery 
CIN 
# 5 15 F 
Rectal bleeding
and 
unconsciousness
Seliac disease 
Surgery of 
Appendectomy 
Bowel obstruction, 
respiratory disturbance 
+intubation
CIMC 
# 6 37 M 
Dyspenea 
exacerbation 
corpulmonale 
Kyphoscoliosis in 
thoracic and lumbar 
spinal area
Mechanical ventilation + 
tracheostomy, partial 
recovery
CIM 
# 7 54 F 
Intra ventricular 
hemorrhage (IVH)
ICHd, IVH and 
hydrocephaly 
Hypertension 
Intubation+ prolonged 
Mechanical ventilation, 
expire
CIM 
# 8 66 M 
Dyspenea 
exacerbation
COPD e 
COPD, Diabetes, 
hypertension
Intubation+ prolonged 
Mechanical ventilation 
CIN/CIM f 
# 9 25 M quadriparesia 
Traumatic SCI 
in C5-C6 levels
- 
Prominent LMNg signs 
(Lower and upper limbs 
weakness, hypotonia and 
hyporeflexia),excess of 
UMNh signs related to SCI 
CIN/CIM 
# 10 55 M 
Progressive lower 
limbs weakness 
LBP 
History of LBP, 
radiculopathy, 
epidural injections 
Treatment for neuropathy 
and CIM, partial recovery 
CIM super-
imposed on 
chronic 
sensorimotor  
polyneuro-
pathy 
# 11 42 F 
Progressive lower 
and upper limbs 
weakness 
FUO (fever with
unknown 
origin) 
First admission 40
days before second 
admission, because 
of FUO and then 
treatment for GBS
Treatment for tuberculosis 
meningitis ,treatment for 
following AMAN and CIM, 
partial recovery with 
persistent paraparesia 
CIM, 
superimpose
d on AMANI 
# 12 44 F 
Progressive lower 
limbs weakness 
Lumbar 
radiculopathy 
LBP and history of 
lumbar disc surgery 
three months ago. 
Complicated with 
pulmonary thrombo emboli 
(PTE), phrenic nerve 
neuropathy
AMAN 
# 13 72 M 
Progressive lower 
limbs weakness 
Upper 
respiratory 
infection
Weakness started 
one week after 
respiratory infection
Treatment for AMAN with 
IVIG and recovery 
AMAN 
# 14 60 M 
Exacerbation of 
COPD 
COPD COPD 
2 weeks after admission 
lower limbs weakness was 
occurred, treatment for 
COPD and following 
AMSAN
AMSANJ 
aCritical illness neuropathy bAcute tubular necrosis CCritical illness myopathy dIntracranial hemorrhage eChronic 
obstructive pulmonary disease fcombined critical illness neuropathy and myopathy (neuromyopathic syndrome) 
gLower motor neuron hUpper motor neuron IAcute motor axonal neuropathy JAcute motor and sensory axonal neuropathy 
Table 1. Characteristics of ill patients with profound weakness, who were referred for electrodiagnosis 
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Needle EMG of the diaphragm muscle is performed in cases with phrenic nerve 
involvement accompanying CIN as well as CIM. For this purpose, needle is inserted 
between the two Anterior Axillary and Medial clavicular lines, through 7th or 8th intercostal 
spaces, exactly over the rib. Neurogenic or myogenic patterns with or without fib/psw could 
be detected in inspiration phase of respiration [6]. 
Phrenic nerve EDX was requested for 4 of 14 patients in the present study. In two patients 
diagnosed with CIN and mixed neuromyopathic syndrome, there was no phrenic nerve 
involvement. In one patient secondary to AMAN, phrenic neuropathy was detected as 
bilateral asymmetric low amplitude CMAPs associated with neurogenic pattern in the 
diaphragm muscle and in one patient secondary to CIM, phrenic nerve involvement was 
revealed as bilateral absent CMAPs along with fib/psw and myogenic pattern in diaphragm 
muscle. 
It should however be borne in mind that phrenic nerve EDX is mostly helpful whenever 
bilateral normal or unilateral abnormal responses are detected. In other words, if responses 
would be absent bilaterally it is difficult to distinguish from technical reasons [2]. 
Treatment: There is no specific treatment for CIN and supportive measures should be taken 
to avoid multi organ failure occurrence. 
5. Critical Illness Myopathy (CIM) 
The most common muscular disorder leading to weakness in ICU is critical illness 
myopathy. CIM is also known as acute quadriplegic myopathy, thick filament myopathy 
and ICU myopathy [1,2]. 
CIM is mostly seen concomitant to the administration of intravenous steroids and NMBAs; 
this complication is frequent in patients with asthma, COPD and administration of high-
dose intravenous methyl-prednisolone [1]. 
Occurrence of one case of CIM and one case of mixed CIM/CIN in our patients’ series with 
the history of hospitalization due to COPD exacerbation or corpulmonale confirms this fact 
(Table 1). This disorder however could also be seen in critically ill patients with sepsis or 
multiorgan failure without history of receiving corticosteroids or NMBAs. Prolonged 
mechanical ventilation per se even with absence of mentioned medications usage could 
cause CIM as well. In some cases, CIM is associated with increase in serum CPK levels (up 
to 10 times the upper limit of normal) [1]. High mortality rates with CIM; even a rate of 30% 
have been reported [4]. Of course, it should be noticed that the mortality cause has mostly 
been due to the sepsis or multiorgan failure rather than the myopathy itself. In present 
study, one case with pure CIM and one case with CIN were expired (Table 1). Survived and 
treated patients would acquire ambulation ability within the following 3-4 months [1]. 
From the histopathologic aspect, type II muscle fiber atrophy is observed more frequently 
than type I. In muscle biopsy, specific signs of myosin loss is often detected which solely 
could not explain the inexcitability of the muscle membrane that occurs with this myopathy. 
Neuromuscular Disorders in Critically-Ill Patients –  
Approaches to Electrophysiologic Changes in Critical Illness Neuropathy and Myopathy 115 
Therefore, the following three factors contributing to reduction in muscle membrane 
excitability are introduced [7]: 
1. Partial depolarization of the resting membrane potential, 
2. Reduced membrane resistance, 
3. Decreased sodium currents 
Furthermore, released cytokines throughout sepsis could be associated with a catabolic state 
in muscles and results in breakdown of structural proteins [1,7]. 
6. Electrophysiologic features in CIM 
Nerve conduction studies demonstrate diminished amplitudes of CMAPs with normal distal 
latencies and conduction velocities. In contrast, SNAPs are normal or mildly reduced (greater 
than 80% of lower limit of normal) [1]. Repetitive stimulation test (RST) is usually normal, but in 
some studies decreasing response after high rate and low rate RST have also been reported [8].  
Electromyography frequently demonstrates prominent fibrillation potentials and 
positive sharp waves (fib/psw), which is rarely accompanied by myotoinc discharges. 
Short duration, small –amplitude and polyphasic MUAPs that recruit early are evident. 
In severe cases, it may be difficult to recruit and activate any MUAPs [1]. Of course, this 
process is reversed and small MUAPs will be appeared again during the recovery period.  
6.1. Direct muscle stimulation technique 
Direct muscle stimulation technique is utilized for differentiation CIM from critical illness 
neuropathy. This method has been reported by Rich and colleagues for first time [7, 9]. In fact, 
direct muscle stimulation bypasses distal motor nerve and neuromuscular junction area. This 
technique is performed by placing a monopolar needle stimulating electrode as cathode in the 
distal third of muscle using 0.1 msec stimulus duration with gradually increasing current from 
10 to 100 mA until a clear twitch is seen. A subdermal needle electrode as active recording 
electrode is placed 1-3 cm from the stimulation electrode. The stimulation intensity is increased 
until a maximal response or direct muscle action potential (dm CMAP) is obtained. Next, 
using the same recording montage, nerve to the muscle is stimulated in the usual manner to 
obtain a nerve- evoked compound muscle action potential (ne CMAP) [2]. As a result muscle 
membrane should retain its excitability, direct muscle stimulation CMAP (dm CMAP) should 
be near normal despite a low or absent nerve stimulation evoked CMAP (ne CMAP). In 
contrast, if the muscle membrane excitability is reduced, both the ne CMAP and dm CMAP 
should be very low [1]. Therefore, in CIM as well as normal people, the ne CMAP/ dm CMAP 
ratio is close to one (1:1), because both amplitudes is proportionally reduced or normal, 
respectively. In CIN or neuromuscular junction disorder, the ratio is much lower and 
approaches zero because of disproportionally lower ne CMAP compared with the dm CMAP. 
In conclusion, absent or low amplitude of dm CMAP with ne CMAP/ dm CMAP greater 
than 0.9 is demonstrated in majority of patients with CIM, While ne CMAP/ dm CMAP ratio 
is 0.5 or less in patients with severe CIN [1]. 
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6.2. Treatment 
There is no medical therapy other than supportive care and treating underlying systemic 
abnormalities (e.g., antibiotics in sepsis). If patients are still receiving high doses of corticosteroids 
or non- depolarizing neuromuscular blockers, the medications should be stopped. 
7. Critical illness neuropathy in combination with myopathy 
(Neuromyopathic syndrome) 
Patients occasionally present with combination of CIN and CIM symptoms, which make it 
complicated to distinguish or detect from each other [1].This condition is named as 
Neuromyopathic Syndrome. 
In our patients’ series, Neuromyopathic Syndrome was observed in 4 from 14 patients, two 
of whom had a combination of CIN and CIM. Third case admitted with chronic severe 
motor and sensory neuropathy symptoms; later presence of myogenic pattern in needle 
EMG revealed additional CIM. Forth patient suffered from FUO (Fever unknown origin) 
and demonstrated CIM which had been superimposed on previously diagnosed AMAN. 
(Table1). One explanation is partly related to this fact, that preexisting neuropathic aspects 
in these patients were completed parallel to disease progression and subsequently myogenic 
process and thick filament myopathy initiated following intubation and administration of 
NMBAs and corticosteroids. We categorized these cases in “Neuromyopathic Syndrome” or 
“combination of critical illness neuropathy and myopathy” group. 
7.1. Electrophysiologic features in combined CIN/CIM 
NCS shows CMAPs and SNAPs both are low amplitude or unobtainable. NCVs are reduced 
but within axonal range (greater than 60-70% of lower limit of normal). Despite of these 
neuropathic features, myogenic process with low amplitude, short duration and polyphasic 
MUAPs are mostly seen, which is occasionally associated with patchy neurogenic changes 
in needle electromyography examination.  
Table 2 illustrates the electrodiagnostic changes in differential diagnosis among critically ill 
patients. 
 
 
Low amplitude 
or absent SNAP
Low amplitude 
or absent CMAP
Reduced NCV > 
60-70%  
of LLNa 
fib/pswb 
Myogenic 
Pattern 
Neurogenic 
Pattern 
CINc ++ ++ - ++ - ++ 
CIMd - ++ - +++ ++ - 
GBSe +/- +/- ++ - - + 
AMANf - + - ++ - ++ 
AMSANg + + - + - + 
CIN/CIMh + + - ++ + +/- 
aLower Limit of Normal, bFibrillation Potentials, cCritical Illness Neuropathy, dCritical Illness Myopathy, eGullian Barre 
Syndrome, fAcute Motor Axonal Neuropathy, gAcute Motor and Sensory Axonal Neuropathy, hcombination of CIN 
and CIM (Neuromyopathic syndrome) 
Table 2. Electrodiagnostic changes in various neuromuscular disorders among critically ill patients  
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8. Prolonged Neuromuscular Junction Blockage: 
Neuromuscular junction block (NMJ block) occurs primarily in diseases like Myastenia 
gravis and Lambert-Eaton myastenic syndrome without simultaneous myopathy or 
neuropathy. However, this complication is frequently observed in association with CIN or 
CIM in critically ill patients who secondarily affected by neuromuscular disorders.  
The definite diagnosis is achieved by performing RST or RNS (Repetitive Nerve Stimulation 
Test) and appearance of decreasing responses and fatigue following repetitive stimulation of 
low rates at 2-3 Hz in Myastenia gravis or NMJ block in combination with CIM. In contrast, 
increment responses and facilitation are observed following stimulation of high rates at 25-
50 Hz in Lambert-Eaton syndrome [10].  
It should be mentioned that pure NMJ block are rarely seen in these patients. In the present 
study, RST was not performed to confirm the simultaneous NMJ block for referred patients, 
who were critically ill and poorly cooperative with definite diagnosis in each category of 
CIN, CIM, AMAN, etc., because of this fact that RST tests are time consuming, painful and 
somewhat unnecessary, since it does not add extra benefit concerning the final therapeutic 
process as well as prognosis in this spectrum of patients. 
In the previous sections, approaches to critically ill patients suspected of having neuropathy 
or myopathy were reviewed, now we turn our focus to the other neuropathies ,which are in 
the differential diagnostic list of profound weakness in the inpatient or ICU setting. These 
disorders are often amenable to treat, so correct diagnosis is important. 
9. Acute inflammatory demylinating  
polyradiculoneuropathy (AIDP) 
The most well known acute neuropathy that results in marked weakness and respiratory 
compromise is Guillain-Barre syndrome (GBS) [2]. GBS is an acquired motor and sensory 
polyradiculneuopathy that is usually demylinating. 
9.1. Electrophysiologic features in GBS 
Demylinating is prescribed with motor nerve conduction velocity less than 60-70% of LLN 
(lower limit of normal),prolonged distal motor latencies and F-waves greater than 25-50% of 
ULN( upper limit of normal), absent F-waves and presence of conduction block or temporal 
dispersion in one or more motor nerves in electrodiagnostic studies. These criteria have 
been defined and reported by Cornblath et al, and are used as research criteria for diagnosis 
of GBS since 1990 [11,12]. 
In our patients’ series, there was no case of GBS and as previously mentioned most of them 
were hospitalized due to primary non-neurologic medical reasons and CIN or CIM was added 
later. Other cases that were presented with weakness in upper and lower extremities with or 
without other medical problems were included in axonal variants of GBS, which is discussed as 
follows. 
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10. Acute motor and sensory axonal neuropathy (AMSAN) 
Feasby and colleagues initially reported this axonal variant of GBS in 1986 [13]. Clinical and 
electrodiagnostic features in AMSAN are indistinguishable from those with AIDP initially 
[5]. Patients with AMSAN refer with a rapidly progressive and generalized weakness which 
progresses within days unlike the AIDP which progresses within weeks. Ophthalmoparesia, 
swallowing disorders, and facial muscles weakness are prominent in these patients. Other 
accompanying symptoms include complete areflexia, sensory loss and autonomic disorders 
such as arrhythmia. Most of these patients would require ventilator and their prognosis are 
often poorer compared with AIDP patients. 
10.1. Electrophysiologic features in AMSAN 
NCS reveal markedly diminished amplitudes or absent CMAPs. SNAPs are also profoundly 
low amplitude or absent. But distal latencies of CMAPs and NCVs, when obtainable, should 
be normal or only mildly affected [5] .In other words, this abnormality would be within 
axonal range(greater than 60-70% of LLN). Neurogenic pattern with large MUAPs with or 
without denervation potentials are seen in needle EMG exam (Table 2). 
In the present study, there was one case with AMSAN had started with above-mentioned 
clinical picture followed by COPD exacerbation and diagnosis was confirmed by EDX 
criteria.  
10.2. Treatment 
Because it is difficult to distinguish AIDP from AMSAN clinically or electrophysiologically, 
at least initially, treatment with plasma exchange or IVIG is warranted [5]. 
11. Acute Motor Axonal Neuropathy (AMAN) 
In northern china, AMAN is the most common variant of GBS [14].Clinical manifestation is 
similar to that of AMSAN and GBS, however distal muscles are affected more severely than 
proximal muscles. Respiratory failure and mechanical ventilation requirement is observed 
in one third of the patients. Unlike AMSAN and GBS no sensory sings are noted. 
Furthermore, Anti-GM1 antibody for Compilobacter jejuni is more frequently detected in 
patients with AMAN especially in Children [15]. 
11.1. Electrophysiologic features in AMAN 
Low amplitude or absent CMAPs with normal SNAPs and mildly reduced NCVs, are the 
characteristic features of nerve conduction studies in AMAN. Other EDx evidences are 
similar to AMSAN as above noted.  
In our patients’ series, there were two cases with AMAN from whom one case was 
associated with phrenic nerve involvement and diaphragm muscle paralysis with 
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respiratory disturbances. There was also a case without respiratory involvement with an 
appropriate response to IVIG (Table 1).  
11.2. Treatment  
It is suggested to treat AMAN patients with IVIG 2mg/kg over 5 days or plasma exchange as 
an alternative. One of large studies reported no significant difference in outcome regardless 
of therapy (IVIG,PE,..) between AIDP and AMAN among 300 patients[15]. 
In conclusion, CIN and CIM have no cure, so in this conditions, underlying disease and 
drugs dose should be treated and adjusted, respectively; despite of this management, 
muscle power weakness lasts several months to recover. AIDP, AMAN and AMSAN, 
however, are curable and therefore distinguish them together is important.  
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